跳到主要內容
big screen image small screen image
Font Size
A
A
A
轉寄 轉寄
(Non-exclusive License)Technology Transfer Enterprise Selection Announcement – The Biomedical Oriented Logistic Dantzig (BOLD) Selector included advanced data analytic scheme, the identification and validation of TAOK1 as dementia biomarker and the detection platform.
Date of Announcement
2025-05-09

1、Technology:The Biomedical Oriented Logistic Dantzig (BOLD) Selector included advanced data analytic scheme, the identification and validation of TAOK1 as dementia biomarker and the detection platform.

2、Inventor:Prof. Shau-Ping Lin/Institute of Biotechnology, National Taiwan University.

3、Enterprise Eligibility:

(1)Industry Category:medical diagnostic reagents, precision medicine, biotechnology, in vitro diagnostics (IVD), data analysis and AI medical-related industries.

(2)Required Technical Know-how:

  • Experience in product development and validation of in vitro diagnostic reagents
  • Statistical models and AI algorithms for biomarker development in precision medicine (e.g., logistic regression, feature screening methods, etc.)
  • Experience in commercialization and regulatory certification (TFDA / FDA) of medical devices or testing platforms

(3)Required Machinery and Equipment: 

  • High-end computing servers or cloud platform resources for bioinformatics analysis and AI training
  • Dust-free laboratory, clinical sample processing and storage equipment

(4)Required Research or Technical Staff:

  • R&D personnel familiar with in vitro diagnostic reagent development, quality control and product validation processes
  • Researchers with background in bioinformatics, statistics, molecular medicine or neuroscience
  • Technical specialists familiar with regulatory affairs and clinical trial design

(5)Other Requirements:

  • Capable of technology licensing, co-development or technology investment cooperation
  • Experience in developing and commercializing new testing platforms or diagnostic products is preferred
  • Willing to cooperate with academic institutions in the long term and invest in clinical validation and market promotion are preferred

4、How to apply:Please go to the Center of Industrial-Academic Cooperation of the Office of Research and Development to inquire about relevant information.

5、Announcement period:Applications will be accepted from the announcement date.

6、Contact window:

Intellectual Property & Licensing Manager:Sierra Wang

TEL:+886-2-3366-6654

Email: sierrawang@ntu.edu.tw

File download:
TechnologyTransferEnterpriseSelecition
File size: 296kb